Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent therapeutical agent primarily utilized for the management of rheumatoid arthritis. This effective substance acts by interfering with the activity of interleukin-6 (IL-6), a communication protein crucial in the inflammatory process. Moreover, Actemra exhibits promise in t